Skip to main content

Table 7 Subgroup analysis of primary outcome

From: Update of the Preventive Antibiotics in Stroke Study (PASS): statistical analysis plan

  Ceftriaxone + standard care (n = …) Standard care (n = …) P OR 95% CI
Favorable outcome (mRS* 0 to 2) - % n/N     
- Ischemic stroke     
- Hemorrhagic stroke     
- Transient ischemic attack (TIA)     
- Other     
Favorable outcome (mRS 0 to 2) - % n/N     
- NIHSS** 1 to 9     
- NIHSS 10 to 30     
Favorable outcome (mRS 0 to 2) - % n/N     
- time to treatment 0 to 6 h     
- time to treatment 6 to 12 h     
- time to treatment 12 to 24 h     
  1. *mRS, denotes modified Rankin Scale.
  2. **NIHSS denotes National Institutes of Health Stroke Scale.